Graham W Slack Selected Research

Graham W Slack Research Topics

Disease

16	Neoplasms (Cancer) 10/2021 - 09/2012
15	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 04/2024 - 10/2012
7	Lymphoma (Lymphomas) 06/2023 - 03/2013
6	Hodgkin Disease (Hodgkin's Disease) 11/2022 - 03/2014
4	Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular) 10/2021 - 03/2014
4	B-Cell Lymphoma (Lymphoma, B Cell) 01/2021 - 03/2014
2	Non-Hodgkin Lymphoma (Lymphosarcoma) 10/2022 - 01/2020
2	Mantle-Cell Lymphoma (Lymphoma, Mantle Cell) 01/2020 - 05/2017
2	Immunoglobulin G4-Related Disease 01/2018 - 04/2017
1	Plasmablastic Lymphoma 10/2022
1	T-Cell Lymphoma (Lymphoma, T Cell) 11/2021
1	Peripheral T-Cell Lymphoma (Lymphoma, T Cell, Peripheral) 11/2021
1	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 10/2021
1	Lymphoproliferative Disorders (Lymphoproliferative Disorder) 01/2020
1	Lymphangioma (Cavernous Lymphangioma) 06/2018
1	Chylous Ascites 06/2018
1	Cystic Lymphangioma (Hygroma) 06/2018
1	Hypergammaglobulinemia (Hyperimmunoglobulinemia) 01/2018
1	Burkitt Lymphoma (Burkitt's Lymphoma) 01/2018
1	Rheumatic Diseases (Rheumatism) 01/2018
1	Leukopenia 08/2017
1	Anemia 08/2017
1	Thrombocytopenia (Thrombopenia) 08/2017
1	Neutropenia 08/2017
1	Leukemia 05/2017
1	Hypereosinophilic Syndrome (Loeffler Endocarditis) 04/2017
1	Eosinophilia 04/2017
1	Rare Diseases (Rare Disease) 04/2017
1	Lymphadenopathy 04/2017
1	Disease Progression 06/2015
1	Hepatitis C 05/2015

Drug/Important Bio-Agent (IBA)

18	Rituximab (Mabthera)FDA Link 10/2021 - 10/2012
9	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2021 - 09/2012
7	Vincristine (Oncovin)FDA LinkGeneric 01/2017 - 10/2012
7	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2017 - 10/2012
6	Prednisone (Sone)FDA LinkGeneric 01/2017 - 10/2012
5	Proteins (Proteins, Gene)FDA Link 01/2021 - 05/2013
3	Biomarkers (Surrogate Marker)IBA 06/2023 - 05/2017
3	Formaldehyde (Formol)FDA Link 10/2021 - 09/2015
3	ParaffinIBA 10/2021 - 09/2015
3	Vinblastine (Vinblastine Sulfate)FDA Link 01/2021 - 09/2012
3	Bleomycin (Blenoxane)FDA LinkGeneric 01/2021 - 09/2012
3	Dacarbazine (DIC)FDA LinkGeneric 01/2021 - 09/2012
2	Immunoglobulins (Immunoglobulin)IBA 10/2018 - 04/2017
2	SteroidsIBA 06/2018 - 04/2017
2	Immunoglobulin G (IgG)IBA 01/2018 - 04/2017
2	Etoposide (VP 16)FDA LinkGeneric 08/2017 - 06/2015
2	Gemcitabine FDA Link 08/2017 - 01/2017
1	TNF Receptor-Associated Factor 3IBA 04/2024
1	SphingolipidsIBA 11/2021
1	MicroRNAs (MicroRNA)IBA 11/2021
1	Messenger RNA (mRNA)IBA 11/2021
1	obinutuzumabIBA 10/2021
1	Monoclonal AntibodiesIBA 10/2021
1	Immune Checkpoint InhibitorsIBA 10/2021
1	RNA (Ribonucleic Acid)IBA 01/2020
1	Protein Isoforms (Isoforms)IBA 01/2020
1	DNA (Deoxyribonucleic Acid)IBA 01/2020
1	AntigensIBA 01/2020
1	ChromatinIBA 01/2019
1	Bendamustine Hydrochloride FDA Link 01/2019
1	hemoglobin Brisbane (HbGL)IBA 01/2018
1	Oxaliplatin (Eloxatin)FDA LinkGeneric 08/2017
1	Lenalidomide (CC 5013)FDA Link 08/2017
1	Immunoglobulin E (IgE)IBA 04/2017
1	Guanosine Diphosphate (GDP)IBA 01/2017
1	Dexamethasone (Maxidex)FDA LinkGeneric 01/2017
1	Cisplatin (Platino)FDA LinkGeneric 01/2017
1	R-CHOP protocolIBA 10/2016
1	Indicators and Reagents (Reagents)IBA 09/2015
1	carboxyl radical (COO-)IBA 09/2015
1	Ifosfamide FDA LinkGeneric 06/2015
1	Cytarabine (Cytosar-U)FDA LinkGeneric 06/2015
1	Methotrexate (Mexate)FDA LinkGeneric 06/2015
1	Antiviral Agents (Antivirals)IBA 05/2015
1	LigandsIBA 03/2014

Therapy/Procedure

8	Therapeutics 06/2023 - 03/2013
7	Drug Therapy (Chemotherapy) 11/2022 - 05/2015
2	Radiotherapy 01/2021 - 01/2021
1	Organ Transplantation 01/2020
1	Aftercare (After-Treatment) 05/2017
1	Salvage Therapy 01/2017
1	Treatment Delay 01/2016
1	Cell Transplantation 06/2015
1	Hematopoietic Stem Cell Transplantation 06/2015
1	Transplantation 06/2015
1	Splenectomy 05/2015
1	Complementary Therapies (Alternative Medicine) 12/2014